ClinicalTrials.govpublic full text
Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection
hiv infections, vaccine, safety, t-cell epitope, acquired immune deficiency syndrome virus, hiv preventive vaccine, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903715
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.